Expert-curated multimodal datasets for translational research, clinical development, real-world evidence generation, and AI

Multimodal
REGULATORY-GRADE
TRANSFERABLE

Aigora curates fit-for-purpose real-world datasets and associated biospecimens to meet the requirements of complex precision medicine R&D.

Discuss your data needs

Use cases

Supporting a broad range of precision medicine applications

Our datasets are built around the diverse R&D needs of pharmaceutical and biotechnology companies.

Translational Research

Real-world data to accelerate translational discovery.

  • Biomarker discovery and validation
  • Disease phenotyping
  • Companion diagnostic development

Clinical Development

Real-world data to advance clinical studies.

  • Clinical trial optimization
  • External control arms
  • Prospective data studies

Real-World Evidence

Real-world data to generate scientific and regulatory evidence.

  • Disease progression analysis
  • Treatment response evaluation
  • Longitudinal outcomes research

AI Model Development

Real-world data to develop and validate AI models.

  • Biomarker pre-screening
  • Clinical decision support
  • Predictive modeling

Our approach

01

Define

We align on the research objectives, intended use case, and initial data requirements.

collaboration
Planning
objectives

02

Assess

We evaluate data availability across our global network, engage clinicians to assess feasibility, and jointly refine project scope.

Ger
SW
USA
FR
+ more

03

Propose

We provide a tailored proposal outlining deliverables, timelines, and commercial terms.

based on years of experience

04

Curate

We coordinate participating sites, approvals, data extraction, and aggregation, while ensuring quality control and privacy safeguards.

coordination
manage
control

05

Deliver

We transfer the final regulatory-grade, research-ready dataset in the agreed format and structure for integration into customer systems

committed delivery
Ready-to-use data

Case studies

From real-world data to impact

See all

Advancing microsatellite instability testing with gastric cancer H&E-stained whole slide image data

Oncology
Biomarker Pre-Screening
Pathology Data
Molecular Test Results
Read case study

Enabling AI-driven research in retinal diseases with longitudinal ophthalmic imaging data

Ophthalmology
Biomarker Discovery
Treatment Response Assessment
Multimodal Imaging Data
Clinical Data
Read case study

Fueling AI-driven early detection of renal cancer with longitudinal multimodal data

Oncology
AI Development
Imaging Data
Clinical Data
Pathology Data
Read case study

Identifying novel tissue biomarkers in inflammatory and autoimmune diseases with curated whole slide image data and biospecimens

Inflammatory Bowel Disease
Scleroderma
Biomarker Discovery
Translational Research
Clinical Data
Read case study

Supporting AI-based germline mutation pre-screening with comprehensive whole slide image datasets

Oncology
Breast Cancer
Germline Mutation Testing
Clinical Data
Pathology Data
Read case study

Why Aigora

Turning study requirements into research-ready datasets

From feasibility assessment to regulatory-grade delivery, Aigora manages every stage of assembling fit-for-purpose research datasets.

Feasibility-led expert curation

We assess study requirements against our network's data, combine internal expertise with clinician input to evaluate feasibility, and refine data specifications while ensuring the final dataset aligns with study goals.

Multimodal data and biospecimens

We assemble patient-level multimodal datasets integrating imaging, clinical, pathology, and molecular data, with associated biospecimens for customer-driven investigations.

European depth, global reach

We source data and biospecimens through hospitals, clinics, and biobanks across our global healthcare partner network, helping to secure sufficient eligible cases and diverse patient populations.

Transferable, regulatory-grade delivery

We deliver research-ready datasets, enabling life sciences teams to process data within their own systems rather than relying on dashboards or outsourced analyses.

End-to-end management

We handle every step of data acquisition, including site selection and coordination, approvals, extraction, aggregation, curation, and quality control, removing operational burden from customers.

Prospective pathways

We set up and manage prospective data collection studies when retrospective data alone cannot meet project requirements.

FAQs

Can you identify enough eligible cases?

Feasibility is established before data acquisition begins.

We assess your inclusion and exclusion criteria against data available across our healthcare partner network, with clinician input where appropriate, to determine whether sufficient eligible cases can be assembled for your study.

What if the data we need isn’t available in routine clinical practice?

Retrospective when possible, prospective when necessary.

We design, set up, and manage protocol-aligned prospective studies to capture longitudinal variables or generate additional study-specific data. The entire process is managed end-to-end, including site selection, approvals, consent, data collection, and quality control.

Have you delivered projects with requirements similar to ours?

Check out our case studies for representative examples.

Our experience spans a wide range of precision medicine use cases. We have delivered retrospective data acquisition projects and prospective data collection studies across multiple data modalities and clinical specialties for translational research, clinical development, real-world evidence generation, and AI applications.

Can you provide biomarker-linked imaging data?

More than image-only datasets.

Imaging data are integrated at the patient level with structured clinical, pathology, and molecular data. Where associated physical biospecimens are available, additional study-specific biomarker data can be generated through our partner laboratories.

Do we get the data, or only insights?

Datasets are transferred to you.

Curated datasets are delivered directly into your infrastructure with appropriate commercial usage rights. There are no closed dashboards or federated read-only restrictions, and analyses are provided only if you request them.

Data modalities

Integrating multimodal data to answer complex research questions

Precision medicine R&D requires multiple data modalities linked at the patient level. We combine imaging, pathology, clinical, and molecular data from our healthcare partner network into datasets tailored to study objectives.

Medical imaging

Medical imaging data across multiple modalities and clinical specialties, with associated reports and linked metadata.

Clinical data

Structured and unstructured patient-level data, including demographics, diagnoses, procedures, medications, clinical notes, and outcomes.

Whole slide images

Digital pathology images derived from biopsies, resections, and other specimen types, with associated metadata.

Pathology data

Specimen-level diagnostic information, including pathology findings, diagnostic classifications, specimen characteristics, and organ site details.

Molecular test results

Molecular and biomarker test results, including genomic, transcriptomic, proteomic, and cytogenetic findings.

Biospecimens

Biological specimens from corresponding data subjects, including tissue, blood, plasma, and serum.